Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Buhmann

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Neuroradiology|November 10, 1998
Computer-assisted three-dimensional reconstruction of the corticospinal system as a reference for CT and MRIC Buhmann, H J Kretschmann
Parkinson'S Disease|December 5, 2018
Stress Management Training (SMT) Improves Coping of Tremor-Boosting Psychosocial Stressors and Depression in Patients with Parkinson's Disease: A Controlled Prospective StudyC Buhmann, D Jungnickel, E Lehmann
Acta Neurologica Scandinavica|September 13, 2002
Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapyC Buhmann, J Gbadamosi, C Heesen
Acta Neurologica Scandinavica|November 7, 2001
Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot studyJ Gbadamosi, C Buhmann, A Moench, et al.
Acta Neurologica Scandinavica|February 24, 2000
IL-1ra serum levels in disease stages of MS--a marker for progression?C Heesen, F Sieverding, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 17, 2002
COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's diseaseM Oechsner, C Buhmann, J Strauss, et al.
Der Nervenarzt|March 30, 2016
[Intercultural adaptation of the AIMS in German language: A scale for abnormal involuntary movements]C Buhmann, A Rizos, D Emmans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantroneC Heesen, M Bruegmann, J Gbdamosi, et al.
Neuro Endocrinology Letters|June 25, 2002
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy usersH J Stuerenburg, K Petersen, T Bäumer, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[When should we start medical treatment in Parkinson disease]C Buhmann, J Klucken, A Korchounov, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Neuroradiology|November 10, 1998
Computer-assisted three-dimensional reconstruction of the corticospinal system as a reference for CT and MRIC Buhmann, H J Kretschmann
Parkinson'S Disease|December 5, 2018
Stress Management Training (SMT) Improves Coping of Tremor-Boosting Psychosocial Stressors and Depression in Patients with Parkinson's Disease: A Controlled Prospective StudyC Buhmann, D Jungnickel, E Lehmann
Acta Neurologica Scandinavica|September 13, 2002
Visual recovery in a man with the rare combination of mtDNA 11778 LHON mutation and a MS-like disease after mitoxantrone therapyC Buhmann, J Gbadamosi, C Heesen
Acta Neurologica Scandinavica|November 7, 2001
Failure of ondansetron in treating cerebellar tremor in MS patients--an open-label pilot studyJ Gbadamosi, C Buhmann, A Moench, et al.
Acta Neurologica Scandinavica|February 24, 2000
IL-1ra serum levels in disease stages of MS--a marker for progression?C Heesen, F Sieverding, C Buhmann, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 17, 2002
COMT-inhibition increases serum levels of dihydroxyphenylacetic acid (DOPAC) in patients with advanced Parkinson's diseaseM Oechsner, C Buhmann, J Strauss, et al.
Der Nervenarzt|March 30, 2016
[Intercultural adaptation of the AIMS in German language: A scale for abnormal involuntary movements]C Buhmann, A Rizos, D Emmans, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 24, 2003
Therapy-related acute myelogenous leukaemia (t-AML) in a patient with multiple sclerosis treated with mitoxantroneC Heesen, M Bruegmann, J Gbdamosi, et al.
Neuro Endocrinology Letters|June 25, 2002
Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy usersH J Stuerenburg, K Petersen, T Bäumer, et al.
Fortschritte Der Neurologie-Psychiatrie|March 3, 2010
[When should we start medical treatment in Parkinson disease]C Buhmann, J Klucken, A Korchounov, et al.
Pageof 4